BRIEF-Flamel Technologies reaches agreement with FDA on protocol for phase III pivotal trial of FT218
October 06, 2016 at 07:41 AM EDT
* Flamel Technologies reaches agreement with fda on protocol for phase III pivotal trial of FT218
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.